CN107076747B - 分子乳房摄影术 - Google Patents

分子乳房摄影术 Download PDF

Info

Publication number
CN107076747B
CN107076747B CN201580039837.XA CN201580039837A CN107076747B CN 107076747 B CN107076747 B CN 107076747B CN 201580039837 A CN201580039837 A CN 201580039837A CN 107076747 B CN107076747 B CN 107076747B
Authority
CN
China
Prior art keywords
mir
breast
individual
carcinoma
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201580039837.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN107076747A (zh
Inventor
书志·陈
史蒂文·C·夸伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atosa Therapeutics
Atossa Therapeutics Inc
Original Assignee
Atosa Therapeutics
Atossa Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atosa Therapeutics, Atossa Genetics Inc filed Critical Atosa Therapeutics
Publication of CN107076747A publication Critical patent/CN107076747A/zh
Application granted granted Critical
Publication of CN107076747B publication Critical patent/CN107076747B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
CN201580039837.XA 2014-06-04 2015-06-02 分子乳房摄影术 Expired - Fee Related CN107076747B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462007830P 2014-06-04 2014-06-04
US62/007,830 2014-06-04
PCT/US2015/033827 WO2015187727A2 (en) 2014-06-04 2015-06-02 Molecular mammography

Publications (2)

Publication Number Publication Date
CN107076747A CN107076747A (zh) 2017-08-18
CN107076747B true CN107076747B (zh) 2021-02-02

Family

ID=54767566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580039837.XA Expired - Fee Related CN107076747B (zh) 2014-06-04 2015-06-02 分子乳房摄影术

Country Status (5)

Country Link
US (1) US20170145515A1 (enExample)
EP (1) EP3152579A4 (enExample)
JP (1) JP6757935B2 (enExample)
CN (1) CN107076747B (enExample)
WO (1) WO2015187727A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107012199A (zh) * 2016-01-28 2017-08-04 上海市东方医院 一种在血浆和血清中检测miRNA的方法
JP6980219B2 (ja) * 2016-08-22 2021-12-15 いであ株式会社 がんを検出、又はがんの進行期を判定する方法
CA3044257A1 (en) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Methods for cancer detection
EP3681491A4 (en) 2017-09-11 2021-06-30 Atossa Therapeutics, Inc. PROCESS FOR MANUFACTURING AND USE OF ENDOXIFES
JP7108715B2 (ja) * 2018-01-25 2022-07-28 パー ホール 乳房障害の治療をモニターするための組成物および方法
GB201907999D0 (en) * 2019-06-05 2019-07-17 Cambridge Entpr Breast cancer detection methods
WO2021003433A1 (en) 2019-07-03 2021-01-07 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen
CN110760513A (zh) * 2019-08-23 2020-02-07 西北工业大学 靶向三阴性乳腺癌细胞PENK基因的miR-506及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042660A2 (en) * 2001-11-14 2003-05-22 Sirbasku David A Screening method for predicting susceptibility to breast cancer
WO2007140352A2 (en) * 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798266A (en) * 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
WO2003077871A2 (en) * 2002-03-15 2003-09-25 Cytyc Health Corporation Method of diagnosis and treatment of breast lesions
EP2217143A4 (en) * 2007-12-11 2015-04-15 Epi Sci Llc ELECTRIC BIOIMPEDANZ ANALYSIS AS A BIOMARKER OF BREAST DENSITY AND / OR BREAST CANCER RISK
JP2012507300A (ja) * 2008-10-30 2012-03-29 カリス ライフ サイエンシズ ルクセンブルク ホールディングス Ｒｎａパターンを評価する方法
EP2350320A4 (en) * 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
WO2011137288A2 (en) * 2010-04-30 2011-11-03 The Ohio State University Mirna networks in cancers and leukemias and uses thereof
CA2853343A1 (en) * 2011-10-24 2013-05-02 Atossa Genetics, Inc. Absorbent paper and use thereof for breast cancer detection
US20140255954A1 (en) * 2011-10-24 2014-09-11 Atossa Genetics, Inc. Method of breast cancer detection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003042660A2 (en) * 2001-11-14 2003-05-22 Sirbasku David A Screening method for predicting susceptibility to breast cancer
WO2007140352A2 (en) * 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Oxytocin: bringing magic into nipple aspiration.;K.P.M.Suijkerbuijk, et al.;《Annals of Oncology》;20071001;第18卷(第10期);第1743页 *
Serum Biomarkers to Differentiate Benign and Malignant Mammographic Lesions.;Susanna Shin, et al.;《JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS》;20070531;第204卷(第5期);摘要，第1066-1068页 *

Also Published As

Publication number Publication date
JP2017527775A (ja) 2017-09-21
US20170145515A1 (en) 2017-05-25
CN107076747A (zh) 2017-08-18
EP3152579A4 (en) 2018-01-17
WO2015187727A3 (en) 2016-01-21
JP6757935B2 (ja) 2020-09-23
EP3152579A2 (en) 2017-04-12
WO2015187727A2 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
Zhu et al. Potential clinical utility of liquid biopsies in ovarian cancer
JP6757935B2 (ja) 分子マンモグラフィ
Takeshita et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma
EP2809801B1 (en) Non-invasive cancer diagnosis
JP6039656B2 (ja) 癌再発の予後予測のための方法および装置
Jovčevska Sequencing the next generation of glioblastomas
EP2358912B1 (en) Methods for assessing rna patterns
JP2019528081A (ja) 子宮内膜症についてのバイオマーカーとしてのマイクロｒｎａ
Zhang et al. Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma
EP3122905B1 (en) Circulating micrornas as biomarkers for endometriosis
JP2022523366A (ja) 癌の診断及び予後に関するバイオマーカーパネル
CA3077800A1 (en) Biomarkers useful for detection of types, grades and stages of human breast cancer
Andreasen Molecular features of adenoid cystic carcinoma with an emphasis on microRNA expression.
Liu et al. Development of a novel serum exosomal MicroRNA nomogram for the preoperative prediction of lymph node metastasis in esophageal squamous cell carcinoma
WO2011154008A1 (en) Microrna classification of thyroid follicular neoplasia
Senaratne et al. Clinical value of circulating microRNAs in diagnosis and prognosis of pancreatic cancer: A systematic review
KR102096499B1 (ko) 대장암 진단 또는 재발 예측을 위한 마이크로rna-3960 및 이의 용도
Huang et al. Clinical translational research of liquid biopsy applications in prostate cancer and other urological cancers
CN103773761B (zh) 检测胃癌的血清/血浆微小rna标志物及其应用
RU2547583C2 (ru) Способ диагностики рака молочной железы
Gordon et al. Genomic medicine for cancer diagnosis
Chamandi miRNA profiling in breast cancer: putative novel biomarkers for diagnosis, prognosis, or therapeutics
Bajpai et al. Biomarkers of Esophageal Cancers and Precancerous Lesions
Bakhsh Deep Sequencing Towards Detection of Novel Exosomal miRNA for Prognosis of Colorectal Cancer
CN120789258A (zh) Pde4dip作为生物标志物在制备用于辅助治疗肾脏足细胞损伤及足细胞病的药剂盒和药物中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Washington State

Applicant after: Atosa therapeutics

Address before: Washington State

Applicant before: ATOSSA GENETICS, Inc.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210202

Termination date: 20210602

CF01 Termination of patent right due to non-payment of annual fee